News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Sensor innovation moves forward to development
This past year inventor Dr. A.T. Charlie Johnson, Rebecca W. Bushnell Professor of Physics and Astronomy in the School of Arts & Sciences, received three issued patents
Updated PCI Ventures Flagship Programs announced
PCI Ventures updated its flagship programs this past year that support University startups.
Penn Medicine researchers receive prestigious NIH 2021 Director’s Awards
The grants, totaling more than $8 million, will support seven high-risk, high-reward research projects
PCI and JPOD included in the Technical.ly Philly list of resources to boost Philly health startups
A list of Penn programs, partners and friends that work together to support new health startups in the Philadelphia region.
Former I-Corps company making breast pumping easier for moms
Adriana Vazquez spent years perfecting her breast pumping bra for company Lilu.
Pennovation Lab welcomes new tenant Interius BioTherapeutics to its innovation ecosystem
Interius BioTherapeutics has signed a 17,743 SF lease advancing cell and gene therapy research at the Pennovation Works innovation ecosystem.
Interius BioTherapeutics Moves to Pennovation Lab
In October 2021, Interius BioTherapeutics (“Interius”) signed a 17,743 SF lease advancing cell and gene therapy research at the Pennovation Works innovation ecosystem.
Washington Post special features on mRNA foundational technology inventors
The Washington Post ran two feature articles profiling Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, PhD, an adjunct professor of Neurosurgery.
Two pioneering RNA scientists win the 2021 Dr. Paul Janssen Award for Biomedical Research
The foundational work that enabled the use of messenger RNA (mRNA) in vaccine development that they're receiving the 2021 Dr. Paul Janssen Award for Biomedical Research,
Penn mRNA Scientists Drew Weissman and Katalin Karikó Receive 2021 Lasker Award, America’s Top Biomedical Research Prize
Drs. Weissman and Karikó’s mRNA technology is recognized for enabling rapid development of highly effective COVID-19 vaccines.